Elisa Fadda

Elisa Fadda

Auto-generated profile, based on publicly available information

Elisa Fadda

School of Biological Sciences, University of Southampton, Southampton, UK

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 March 2023 in JACS Au
Verified
Journal Article
Open access
Serge PerezSerge Perez
Serge Perez
OMOlga Makshakova
Olga Makshakova
JAJesus Angulo
Jesus Angulo
Emiliano BediniEmiliano Bedini
Emiliano Bedini
ABAntonella Bisio
Antonella Bisio
SBSylvie Ricard Blum
Sylvie Ricard Blum

20 September 2013 in Glycobiology
Verified
Journal Article
Open access
PDF file
OGOliver C Grant
Oliver C Grant
HSHannah Mk Smith
Hannah Mk Smith
DFDaria Firsova
Daria Firsova
EFElisa Fadda
Elisa Fadda
RWRobert J Woods
Robert J Woods
Changes in cell-surface glycan patterns are markers of the presence of many different disease and cancer types, offering a relatively untapped niche for glycan-targeting reagents and therapeutics in diagnosis and treatment. Of paramount importance for the success of any glycan-targeting reagent is the ability to specifically recognize the target among the plethora of different glycans that exist in the human body. The preeminent technique for defining specificity is glycan array screening, in which a glycan-binding protein (GBP) can be simultaneously screened against multiple glycans. Glycan array screening has provided unparalleled insight into GBP specificity, but data interpretation suffers from difficulties in identifying false-negative binding arising from altered glycan presentation, associated with the linker used to conjugate the glycan to the surface. In this work, we model the structure and dynamics of the linkers employed in the glycan arrays developed by the Consortium for Functional Glycomics. The modeling takes into account the physical presence and surface polarity of the array, and provides a structure-based rationalization of false-negative results arising from the so-called “linker effect.” The results also serve as a guide for interpreting glycan array screening data in a biological context; in particular, we show that attempts to employ natural amino acids as linkers may be prone to unexpected artifacts compromising glycan recognition.

25 November 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
AHAoife M. Harbison
Aoife M. Harbison
CFCarl A. Fogarty
Carl A. Fogarty
TPToan K. Phung
Toan K. Phung
ASAkash Satheesan
Akash Satheesan
BSBenjamin Schulz
Benjamin Schulz
EFElisa Fadda
Elisa Fadda
The N-glycans structures affect the mechanistic properties of the SARS-CoV-2 S, fine-tuning the glycoprotein. The evolution of the glycan shield led to the loss of N370 glycosylation in SARS-CoV-2 S, where the RBD cleft can bind host-cell glycans.

14 October 2024 in Nature Methods
Verified
Journal Article
Open access
PDF file
CICallum M. Ives
Callum M. Ives
OSOjas Singh
Ojas Singh
SDSilvia D’aNdrea
Silvia D’aNdrea
CFCarl A. Fogarty
Carl A. Fogarty
AHAoife M. Harbison
Aoife M. Harbison
EFElisa Fadda
Elisa Fadda
Despite ground-breaking innovations in experimental structural biology and protein structure prediction techniques, capturing the structure of the glycans that functionalize proteins remains a challenge. Here we introduce GlycoShape (https://glycoshape.org), an open-access glycan structure database and toolbox designed to restore glycoproteins to their native and functional form in seconds. The GlycoShape database counts over 500 unique glycans so far, covering the human glycome and augmented by elements from a wide range of organisms, obtained from 1 ms of cumulative sampling from molecular dynamics simulations. These structures can be linked to proteins with a robust algorithm named Re-Glyco, directly compatible with structural data in open-access repositories, such as the Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB) and AlphaFold Protein Structure Database, or own. The quality, performance and broad applicability of GlycoShape is demonstrated by its ability to predict N-glycosylation occupancy, scoring a 93% agreement with experiment, based on screening all proteins in the PDB with a corresponding glycoproteomics profile, for a total of 4,259 N-glycosylation sequons.

29 October 2021 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
HBHaroldas Bagdonas
Haroldas Bagdonas
CFCarl A. Fogarty
Carl A. Fogarty
EFElisa Fadda
Elisa Fadda
JAJon Agirre
Jon Agirre